Search News + Media

Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.

Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008.

Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.

Rutgers Cancer Institute of New Jersey and Tufts Medical Center Collaboration Published in Journal of Clinical Oncology.

Internationally esteemed "think and do" tank moved to the new Center for Biomedical System Design within Tufts MC's Institute for Clinical Research and Health Policy Studies on July 5.

New Formula predicts with high accuracy which patients with recurring stroke would benefit from PFO closure.

Iris Z. Jaffe, MD, PhD has been elected into the Association of American Physicians (AAP).

A national clinical trial led by Tufts Children’s Hospital researchers has found that both targeted genome sequencing and whole genome sequencing may help diagnose genetic abnormalities in neonates and infants. However, the technology and interpretations of results continue to have significant limitations that require further research and understanding.

Internationally esteemed clinician and health equity researcher, Karen Freund, MD, MPH has been named Physician-in-Chief and Chair of the Department of Medicine at Tufts Medical Center, effective February 1. She will also assume the role of Chair of the Department of Medicine at Tufts University School of Medicine, both effective February 1.

Dr. Michael House Receives Grand Prize for Novel Device to Prevent Preterm Birth.

Tufts Medical Center has named an interim Chief Scientific Officer, Dr. John Wong.

Kennedy will be hosting a virtual town hall today featuring Karen Freund, MD, from Tufts Medical Center.

A national clinical trial has found that vitamin D supplementation does not significantly reduce the likelihood of developing type 2 diabetes in people who are at high risk for the disease and already have sufficient vitamin D levels.